4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pasithea Therapeutics Corp. (KTTA) operates in the Biotechnology industry and is headquartered in Miami Beach, United States with about 5 employees. Its market capitalization is roughly $15 million. In the fiscal year ended 2025-12-31, KTTA reported $0M in revenue and ($20M) in net income.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | $0M | $0M |
| Operating Income (EBIT) | ($21M) | ($14M) | ($16M) | ($13M) | — |
| Net Income | ($20M) | ($14M) | ($16M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($10M) | ($3M) | ($4M) | ($4M) | — |
| Net Income | ($3M) | ($10M) | ($3M) | ($4M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $60M | $16M | $26M | $45M | — |
| Total Liabilities | $5M | $1M | $3M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KTTA viewer.
About TickerBase · Data methodology & sources